CoChat

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

Open access
Zhu, Hongyi, Zhou, Lenian, Wang, Qiuke, Cai, Qianying, Yang, Fan, Jin, Hanqiang, Chen, Yiwei, Song, Yanyan, Zhang, Changqing · 2023 · Annals of the Rheumatic Diseases
Cited by 129

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Obesity is a risk factor for knee osteoarthritis (KOA) development and progression. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are indicated for type 2 diabetes mellitus (T2DM) and obesity. However, whether KOA patients can benefit from GLP-1RA therapies has not been sufficiently investigated, especially in the long term. METHODS: The Shanghai Osteoarthritis Cohort study is a prospective, observational, multicentre study of >40 000 adults with clinically diagnosed osteoarthritis aged >45 years in Shanghai. We identified all KOA participants with comorbid T2DM enrolled from 1 January 2011 to 1 January 2017. Primary outcome was incidence of knee surgery after enrolment. Secondary outcomes included pain-relieving medication use, number of intra-articular therapies, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and medial femorotibial joint cartilage thickness. To evaluate the effects of GLP-1RA, we performed before-and-after comparison and comparison with participants who had no GLP-1RA exposure. RESULTS: For an intergroup comparison (non-GLP-1RA vs GLP-1RA), more weight loss (adjusted mean difference in weight change from baseline -7.29 kg (95% CI -8.07 to -6.50 kg), p<0.001) and lower incidence of knee surgery (93/1574 (5.9%) vs 4/233 (1.7%), adjusted p=0.014) were observed in the GLP-1RA group. Statistically significant differences in mean change from baseline for the WOMAC total and pain subscale scores were observed (adjusted mean difference in WOMAC total score -1.46 (95% CI -2.84 to -0.08), p=0.038; adjusted mean difference in WOMAC pain subscore -3.37 (95% CI -5.79 to -0.94), p=0.007). Cartilage-loss velocity of the medial femorotibial joint was significantly lower in the GLP-1RA group postadjustment for baseline characteristics (adjusted mean difference -0.02 mm (95% CI -0.03 to -0.002 mm), p=0.004). For the before-and-after comparison within the GLP-1RA group, we observed a significant decrease of symptom-relieving medication consumption and cartilage loss velocity of medial femorotibial joint (after-treatment vs before-treatment: -0.03±0.05 vs -0.05±0.07 mm/year, p<0.001). The association between GLP-1RA exposure and decreased incidence of knee surgery was mediated by weight reduction (mediation proportion: 32.1%), instead of glycaemic control (too small to calculate). CONCLUSION: With sufficient treatment duration, GLP-1RA therapies might be disease-modifying for KOA patients with comorbid T2DM, possibly mediated by weight loss. Further investigation is needed to elucidate effects of GLP-1RA on disease process, joint structure and patient-reported outcomes of osteoarthritis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/ard-2023-223845

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 40

  1. Hunter, 2014, The individual and socioeconomic impact of osteoarthritis, Nat Rev Rheumatol, 10, 437, 10.1038/nrrheum.2014.44 · DOI · Paper page
  2. Long, 2022, Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019, Arthritis & Rheumatology, 74, 1172, 10.1002/art.42089 · DOI · Paper page
  3. Reyes, 2016, Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: A population-based cohort study, Arthritis Rheumatol, 68, 1869, 10.1002/art.39707 · DOI · Paper page
  4. Arden, 2021, Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines, Nat Rev Rheumatol, 17, 59, 10.1038/s41584-020-00523-9 · DOI · Paper page
  5. Fernandes, 2013, EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis, Ann Rheum Dis, 72, 1125, 10.1136/annrheumdis-2012-202745 · DOI · Paper page
  6. Zhao, 2023, Global burden of osteoarthritis associated with high body mass index in 204 countries and territories, 1990-2019: findings from the global burden of disease study 2019, Endocrine, 79, 60, 10.1007/s12020-022-03201-w · DOI
  7. Liu, 2022, Disease burden of osteoarthritis of the knee and hip due to a high body mass index in China and the USA: 1990-2019 findings from the global burden of disease study 2019, BMC Musculoskelet Disord, 23, 63, 10.1186/s12891-022-05027-z · DOI
  8. Messier, 2022, Effect of diet and exercise on knee pain in patients with osteoarthritis and overweight or obesity: A randomized clinical trial, JAMA, 328, 2242, 10.1001/jama.2022.21893 · DOI
  9. Gudbergsen, 2021, Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial, Am J Clin Nutr, 113, 314, 10.1093/ajcn/nqaa328 · DOI · Paper page
  10. Yannakoulia, 2019, Dietary modifications for weight loss and weight loss maintenance, Metabolism, 92, 153, 10.1016/j.metabol.2019.01.001 · DOI · Paper page
  11. Neogi, 2013, Epidemiology of osteoarthritis, Rheum Dis Clin North Am, 39, 1, 10.1016/j.rdc.2012.10.004 · DOI · Paper page
  12. Kalra, 2021, Contemporary classification of glucagon-like peptide 1 receptor agonists (Glp1Ras), Diabetes Ther, 12, 2133, 10.1007/s13300-021-01113-y · DOI · Paper page
  13. Jafarzadeh, 2020, Mediating role of bone marrow lesions, Synovitis, pain sensitization, and depressive symptoms on knee pain improvement following substantial weight loss, Arthritis Rheumatol, 72, 420, 10.1002/art.41125 · DOI
  14. Reijman, 2004, Validity, reliability, and applicability of seven definitions of hip osteoarthritis used in Epidemiological studies: a systematic appraisal, Annals of the Rheumatic Diseases, 63, 226, 10.1136/ard.2003.010348 · DOI
  15. Skou, 2020, Comparison of three sets of clinical classification criteria for knee osteoarthritis: a cross-sectional study of 13,459 patients treated in primary care, Osteoarthritis and Cartilage, 28, 167, 10.1016/j.joca.2019.09.003 · DOI
  16. Wang, 2021, Diagnosis of early stage knee osteoarthritis based on early clinical course: data from the CHECK cohort, Arthritis Res Ther, 23, 217, 10.1186/s13075-021-02598-5 · DOI
  17. Clement, 2018, What is the minimum clinically important difference for the WOMAC index after TKA?, Clin Orthop Relat Res, 476, 2005, 10.1097/CORR.0000000000000444 · DOI · Paper page
  18. Bellamy, 2015, Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis, Arthritis Care & Research, 67, 972, 10.1002/acr.22538 · DOI
  19. Moseley, 2002, A controlled trial of Arthroscopic surgery for osteoarthritis of the knee, N Engl J Med, 347, 81, 10.1056/NEJMoa013259 · DOI · Paper page
  20. Sihvonen, 2020, Arthroscopic partial Meniscectomy for a degenerative Meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish degenerative Meniscus lesion study) trial, Br J Sports Med, 54, 1332, 10.1136/bjsports-2020-102813 · DOI
  21. Stahel, 2018, Surgeon practice patterns of Arthroscopic partial Meniscectomy for degenerative disease in the United States: A measure of low-value care, JAMA Surg, 153, 494, 10.1001/jamasurg.2017.6235 · doi:10.1001/jamasurg.2017.6235
  22. Rickert, 2020, On patient safety: Orthopaedic Surgeons must stop performing Arthroscopic partial Meniscectomy on patients with Arthritic knees, Clin Orthop Relat Res, 478, 28, 10.1097/CORR.0000000000001072 · doi:10.1097/corr.0000000000001072
  23. Eckstein, 2009, One year change of knee cartilage morphology in the first release of participants from the osteoarthritis initiative progression Subcohort: association with sex, body mass index, symptoms and radiographic osteoarthritis status, Ann Rheum Dis, 68, 674, 10.1136/ard.2008.089904 · DOI
  24. Eckstein, 2006, Double echo steady state magnetic resonance imaging of knee Articular cartilage at 3 Tesla: a pilot study for the osteoarthritis initiative, Annals of the Rheumatic Diseases, 65, 433, 10.1136/ard.2005.039370 · DOI · Paper page
  25. Boer, 2023, Obesity Pharmacotherapy: Incretin action in the central nervous system, Trends Pharmacol Sci, 44, 50, 10.1016/j.tips.2022.11.001 · DOI
  26. Leyland, 2016, Obesity and the relative risk of knee replacement surgery in patients with knee osteoarthritis: A prospective cohort study, Arthritis & Rheumatology, 68, 817, 10.1002/art.39486 · DOI
  27. Rosa, 2009, Impaired glucose Transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in Chondrocytes from Osteoarthritic versus normal human cartilage, Arthritis Res Ther, 11, R80, 10.1186/ar2713 · DOI · Paper page
  28. Wang, 2021, Diabetes mellitus accelerates the progression of osteoarthritis in streptozotocin-induced diabetic mice by deteriorating bone Microarchitecture, bone mineral composition, and bone strength of Subchondral bone, Ann Transl Med, 9, 768, 10.21037/atm-20-6797 · DOI
  29. Schett, 2013, Diabetes is an independent Predictor for severe osteoarthritis: results from a longitudinal cohort study, Diabetes Care, 36, 403, 10.2337/dc12-0924 · DOI · Paper page
  30. Lu, 2018, Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan, PLoS ONE, 13, e0191242, 10.1371/journal.pone.0191242 · DOI
  31. Tingley, 2014, Mediation: R package for causal mediation analysis, J Stat Softw, 59, 10.18637/jss.v059.i05 · DOI · Paper page
  32. Mei, 2019, Liraglutide suppresses TNF-Α-induced degradation of extracellular matrix in human Chondrocytes: a therapeutic implication in osteoarthritis, Am J Transl Res, 11, 4800
  33. Brennan, 2022, Weight loss and exercise Differentially affect insulin sensitivity, body composition, cardiorespiratory fitness, and muscle strength in older adults with obesity: A randomized controlled trial, J Gerontol A Biol Sci Med Sci, 77, 1088, 10.1093/gerona/glab240 · DOI · Paper page
  34. Dieppe, 2005, Pathogenesis and management of pain in osteoarthritis, Lancet, 365, 965, 10.1016/S0140-6736(05)71086-2 · DOI · Paper page
  35. Gersing, 2017, Is weight loss associated with less progression of changes in knee Articular cartilage among obese and overweight patients as assessed with MR imaging over 48 months? data from the osteoarthritis initiative, Radiology, 284, 508, 10.1148/radiol.2017161005 · DOI
  36. Anandacoomarasamy, 2012, Weight loss in obese people has structure-modifying effects on medial but not on lateral knee Articular cartilage, Ann Rheum Dis, 71, 26, 10.1136/ard.2010.144725 · DOI
  37. McAlindon, 2017, Effect of intra-Articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: A randomized clinical trial, JAMA, 317, 1967, 10.1001/jama.2017.5283 · DOI · Paper page
  38. Jüni, 2015, Intra-Articular corticosteroid for knee osteoarthritis, Cochrane Database Syst Rev, 2015
  39. Solomon, 2010, The comparative safety of Analgesics in older adults with arthritis, Arch Intern Med, 170, 1968, 10.1001/archinternmed.2010.391 · DOI · Paper page
  40. da Costa, 2021, Effectiveness and safety of non-Steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis, BMJ, 375, 2321, 10.1136/bmj.n2321 · DOI · Paper page

Cited by

See all 129

Metadata

Authors
Zhu, H., Zhou, L., Wang, Q., Cai, Q., Yang, F., Jin, H., Chen, Y., Song, Y., & Zhang, C.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2023-09
Volume
82
Issue
9
Pages
1218-1226
ISSN
0003-4967 (ISSN-L)
OpenAlex
W4378799384
Cited by
129
References
19
FWCI
22.33
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • National Natural Science Foundation of China (82002324)
  • Shanghai Shen Kang Hospital Development Center, Clinical Research Plan of SHDC (SHDC2020CR6019)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort. https://app.cochat.ai/papers/10.1136/ard-2023-223845
The paper
Zhu, H., Zhou, L., Wang, Q., Cai, Q., Yang, F., Jin, H., Chen, Y., Song, Y., & Zhang, C. (2023). Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2023-223845

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.